NCT07393529 A Pilot Randomized Controlled Trial of a Social Network Intervention
| NCT ID | NCT07393529 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Rochester |
| Condition | Advanced Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 70 participants |
| Start Date | 2026-04-10 |
| Primary Completion | 2029-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 70 participants in total. It began in 2026-04-10 with a primary completion date of 2029-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a pilot randomized controlled trial to assess the feasibility, acceptability, appropriateness, and structure of the SONATA intervention. In addition, it will assess the preliminary efficacy of SONATA compared to enhanced usual care among 70 older adults with advanced cancer.
Eligibility Criteria
Patients Inclusion criteria: * Age ≥65 years * A diagnosis of advanced or likely incurable cancer, as determined by the primary oncologist * Able to speak English * Able to provide informed consent Exclusion criteria: * Any psychiatric or cognitive impairments interfering with participation as determined by the oncology team * Unwilling to complete study procedures Social Network Members (if available, for intervention arm only) Inclusion criteria: * Age ≥18 years * Identified as an SN member by the patient in the intervention arm * Able to speak English * Able to provide informed consent Exclusion criteria: • Unwilling to complete study procedures
Contact & Investigator
Kah Poh Loh
PRINCIPAL INVESTIGATOR
University of Rochester
Frequently Asked Questions
Who can join the NCT07393529 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Advanced Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07393529 currently recruiting?
Yes, NCT07393529 is actively recruiting participants. Contact the research team at Kahpoh_Loh@URMC.Rochester.edu for enrollment information.
Where is the NCT07393529 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT07393529 clinical trial?
NCT07393529 is sponsored by University of Rochester. The principal investigator is Kah Poh Loh at University of Rochester. The trial plans to enroll 70 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.